PAREXEL

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

Four years after being taken private, Parexel has been sold again, with Goldman Sachs’ private equity arm and EQT paying $8.5 billion to claim ownership of the contract research organisation. The handover comes four years after Pamplona Capital Management bought the company for around $5 billion, and just a few weeks after lab tech company …

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal Read More »

What’s coming up at MedCity INVEST Precision Medicine Day 3?

The final day of the conference, Friday, December 11, includes a panel on precision medicine investment trends, a look at clinical trial design innovation and the life sciences track of our Pitch Perfect startup contest. Register now!